1-Test Cyp 100 (DHB) β Dihydroboldenone Cypionate by Dragon Pharma
1-Test Cyp 100 is Dragon Pharma's formulation of Dihydroboldenone Cypionate (DHB) at 100mg/ml β the 5-alpha reduced form of Boldenone (Equipoise), carrying an anabolic ratio of 200 and androgenic ratio of 100 with zero aromatisation. DHB is structurally to Boldenone what DHT is to testosterone β the 5-alpha reduced metabolite that cannot aromatise, produces harder, drier muscle gains, and carries greater androgenic activity in androgen-sensitive tissues. It is also widely noted for significant injection site pain that requires specific management strategies.
Also searched as: DHB, Dihydroboldenone Cypionate, 1-Testosterone Cypionate, 1-Test Cyp, DHB Dragon Pharma.
What DHB Is β The Dihydroboldenone Structure
The relationship between DHB and Boldenone (EQ) mirrors that between DHT and testosterone:
- Boldenone (Equipoise) is a mild aromatising AAS with anabolic ratio ~100 and androgenic ratio ~50. It aromatises to estradiol at approximately 50% the rate of testosterone
- Dihydroboldenone (DHB) is the 5-alpha reduced form of Boldenone β exactly as DHT is the 5-alpha reduced form of testosterone. The 5-AR enzyme reduces the double bond at the C1-C2 position of Boldenone, producing DHB
- Like DHT versus testosterone: DHB cannot aromatise (the 5-alpha reduction prevents aromatase from acting on it), has higher androgenic potency than its parent compound, and produces harder, more defined gains without water retention
- DHB's anabolic ratio of 200 is double testosterone's (100) β making it genuinely anabolic β while the androgenic ratio of 100 matches testosterone exactly. This anabolic:androgenic profile (2:1 ratio) is superior to testosterone's 1:1 while producing no estrogen
- DHB does not convert to DHT via 5-AR (it already is the 5-AR reduced form) β the standard Finasteride concern about DHT conversion does not apply
DHB vs Boldenone (EQ) β The Parent/Reduced Form Comparison
| Parameter |
DHB (Dihydroboldenone) |
Boldenone (EQ) |
| Anabolic ratio |
200 |
~100 |
| Androgenic ratio |
100 |
~50 |
| Aromatisation |
None |
~50% of testosterone rate |
| 5-AR conversion |
Already 5-AR reduced β no further conversion |
Converts to DHB via 5-AR |
| Water retention |
None β dry gains |
Minimal from modest aromatisation |
| Erythropoiesis |
Less pronounced than EQ |
Pronounced β significant RBC increase |
| Injection pain |
Significant β specific management required |
Minimal |
| Available esters |
Cypionate (this product) |
Undecylenate (EQ 300/500) |
The Injection Pain Reality β An Honest Assessment
DHB's injection site pain is consistently underrepresented in competitor content and must be addressed directly:
- Dihydroboldenone Cypionate is notorious in the bodybuilding community for producing significant, sometimes severe injection site pain β not the mild post-injection soreness associated with compounds like Testosterone Enanthate, but pronounced pain, swelling and sometimes redness lasting 3-7 days after each injection
- The mechanism is not fully established but is believed to involve the compound's interaction with local tissue at the injection site β DHB at higher concentrations in a small oil depot is particularly irritating to surrounding muscle tissue
- Management strategies that meaningfully reduce (but do not eliminate) pain: diluting DHB with a less irritating oil compound (MCT oil alone, or drawing testosterone enanthate into the same syringe) β a 50:50 blend of DHB with another compound typically reduces pain substantially; limiting per-site injection volume to 1ml maximum; strict site rotation with minimum 48-72 hours before reinjecting the same site; using a slow, controlled injection technique with a smaller gauge needle
- Users who cannot tolerate the injection site pain from DHB are not making poor choices by switching to alternative lean mass compounds β this is a real and significant practical limitation
Effects and Benefits
- Lean, dry mass gains β no aromatisation means no water retention; gains are quality muscle tissue
- Anabolic ratio of 200 β double testosterone's anabolic potency at equivalent mg doses
- No AI required for DHB itself β zero estrogenic activity from this compound
- No conversion to DHT via 5-AR β already the 5-AR reduced form; no additional androgenic scalp/prostate activity from 5-AR conversion
- Moderately long duration from Cypionate ester β ~8-day half-life, twice-weekly injection
- Hardness and muscle density improvement β consistent with non-aromatising lean compounds
Dosage and Administration
| Experience Level |
Weekly Dose |
Volume at 100mg/ml |
Frequency |
Notes |
| First DHB cycle |
200β300 mg/week |
2β3 ml/week |
Twice weekly (1β1.5ml per site) |
Assess pain tolerance; blend with Test E if needed |
| Experienced |
300β400 mg/week |
3β4 ml/week |
Twice weekly |
Keep per-site volume β€1ml to manage pain |
Given injection pain, blending DHB in the same syringe with Testosterone Enanthate or Masteron Enanthate at 50:50 is a widely used strategy that significantly reduces site discomfort. The Cypionate ester provides ~8-day half-life β twice-weekly injection maintains stable blood levels. The testosterone base is strongly recommended alongside DHB; DHB alone provides no esterogenic support and complete HPG suppression still occurs.